A new drug may prove to be a game changer in Alzheimer’s research following the results of an incredible trial.

Patients administered low-dose diranersen injections showed 54% less decline on a test of memory and thinking over nearly two years, suggesting the experimental treatment could slow the deadly disease more effectively than any therapy developed to date, per the Telegraph .

It is also the first drug to show a decline in tau, a protein that forms harmful tangles linked to brain cell death.

The diranersen injections use gene-silencing technology to confront Alzheimer’s at its source, blocking the RNA messages that signal for brain cells…

Read the full article at NYPOST.COM